Minhui Pharmaceuticals completes $131 million Pre-IPO financing round.

On August 8th, it was announced that Minghuai Pharmaceuticals had completed a pre-IPO round of financing of $131 million. This round of financing was led by internationally renowned healthcare investment institution Orbimed, with joint leadership from Qiming Venture Partners, and continued support from existing shareholder TF Capital. Additionally, the company has brought in several high-quality institutional investors including Boyuan Capital, Wuyuan Capital, Shizhen Capital, and Junyi Investment. Representatives from Orbimed and Qiming Venture Partners will join the company's board of directors.